SCHEMBL7443089

SCHEMBL7443089

CCOC(=O)[C@@H](N)Cc1cn[nH]n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.43
▸ TRPM8 Q7Z2W7 1/20 0.42
▸ MME P08473 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SCN9A Q15858 1/20 0.37
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ AAK1 Q2M2I8 1/20 0.33
▸ OPRM1 P35372 1/20 0.33
▸ OPRD1 P41143 1/20 0.33
▸ OPRK1 P41145 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29702411 0.82 MME (0.36) NAMPTTRPM8MMEALDH1A1KDM4E
SCHEMBL5431495 0.74 CA12 (0.50) NAMPTTRPM8ALDH1A1KDM4ETDP1
SCHEMBL19699077 0.73 NLRP3 (0.47) ALDH1A1KDM4EMEN1KMT2ACYP1A2
SCHEMBL93942 0.73 SCN9A (0.39) ALDH1A1KDM4EMEN1KMT2ASCN9A
SCHEMBL93941 0.73 SCN9A (0.39) ALDH1A1KDM4EMEN1KMT2ASCN9A
Hydrochloric Acid SCHEMBL28535122 0.72 SCN9A (0.38) ALDH1A1KDM4EMEN1KMT2ASCN9A
Hydrochloric Acid SCHEMBL3069711 0.72 SCN9A (0.38) ALDH1A1KDM4EMEN1KMT2ASCN9A
Hydrochloric Acid SCHEMBL3069712 0.72 SCN9A (0.38) ALDH1A1KDM4EMEN1KMT2ASCN9A
SCHEMBL13083202 0.71 SCN9A (0.40) ALDH1A1KDM4EMEN1KMT2ASCN9A
SCHEMBL93943 0.70 CYP3A4 (0.65) ALDH1A1MEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6384028-B1 TREATMENT OF CARDIOVASCULAR DISORDERS, ANTICOAGULANTS AND VALVE REPLACEMENT FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-05-07 — — US disclosed
WO-1996029309-A1 N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-09-26 — — WO disclosed
Send feedback